Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian Cancer.
Researchers found artesunate, a drug for severe malaria, enhances cell death in ovarian cancer when combined with navitoclax. This combo shows promising antineoplastic effects in both cell and animal models, hinting at a potential new treatment option for ovarian cancer.
- McCorkle JR et al (2024).
- Cancers (Basel).
- PubMed:
- 38610999